nach oben

International Ophthalmology

Erschienen in:

03.01.2019 | Original Paper

The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy

verfasst von: Yan-Ni Zhu, Guo-Jin Zuo, Qi Wang, Xiao-Ming Chen, Jin-Kui Cheng, Shu Zhang

Erschienen in: International Ophthalmology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To understand the involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy (DR).

Methods

This study established rat models of diabetes mellitus (DM), which were divided into Normal, DM, DM + CHPG (mGluR5 agonist CHPG), and DM + MTEP (mGluR5 antagonist MTEP) groups. The blood glucose and weight of rats were recorded. EB staining was used for observation of blood–retinal barrier (BRB) damage. Neural retina function was measured by pattern electroretinogram (ERG). PAS and NG2 immunohistochemistry were conducted to evaluate the retinal vascular morphology. The TUNEL assay and active caspase-3 immunohistochemistry were performed to detect retinal cell apoptosis. Additionally, the expression levels of superoxide dismutase (SOD) and methylenedioxyamphetamine (MDA) were measured. Moreover, expression levels of mGluR5 and JNK pathway-related proteins were detected by western blot.

Results

When compared with control rats, rats in the DM group showed decreased amplitude and latency of the peak times in the ERG test; further, DM group rats presented increases in blood glucose, BRB permeability, a retinal capillary area density, retinal cell apoptosis with an increased number of active caspase-3-positive cells, MDA level, mGluR5 levels, and the ratio of p-JNK/JNK, and they showed reductions in body weight and SOD activity, as well as in the number of pericytes and in the pericyte coverage (all P < 0.05). However, rats in DM + CHPG group had stronger negative effects than those in DM group (all P < 0.05). Rats from DM + MTEP group showed an opposite trend compared with the DM rats (all P < 0.05).

Conclusion

The level of mGluR5 in DR rats was upregulated, whereas inhibition of mGluR5 alleviated retinal pathological damage and decreased cell apoptosis to improve DR via suppression of the JNK signaling pathway, which provided a scientific theoretical basis for the clinical treatment of DR.

El-Asrar AM (2012) Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol 19:70–74CrossRef

Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564CrossRef

Huang H, He J, Johnson D, Wei Y, Liu Y et al (2015) Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition. Diabetes 64:200–212CrossRef

Saxena R, Singh D, Saklani R, Gupta SK (2016) Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects. Eye Brain 8:1–13CrossRef

Wen D, Song W, Liu S, Tan X, Liu F (2015) Upregulated expression of N-methyl-D-aspartate receptor 1 and nitric oxide synthase during form-deprivation myopia in guinea pigs. Int J Clin Exp Pathol 8:3819–3826PubMedPubMedCentral

Ji M, Miao Y, Dong LD, Chen J, Mo XF et al (2012) Group I mGluR-mediated inhibition of Kir channels contributes to retinal Muller cell gliosis in a rat chronic ocular hypertension model. J Neurosci 32:12744–12755CrossRef

Alexander GM, Godwin DW (2006) Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Res 71:1–22CrossRef

Gerber U, Gee CE, Benquet P (2007) Metabotropic glutamate receptors: intracellular signaling pathways. Curr Opin Pharmacol 7:56–61CrossRef

Gao F, Li F, Miao Y, Dong LD, Zhang SH et al (2015) Group I metabotropic glutamate receptor agonist DHPG modulates Kir4.1 protein and mRNA in cultured rat retinal Muller cells. Neurosci Lett 588:12–17CrossRef

10.

Yang L, Mao L, Chen H, Catavsan M, Kozinn J et al (2006) A signaling mechanism from Gαq-protein-coupled metabotropic glutamate receptors to gene expression: role of the c-Jun N-terminal kinase pathway. J Neurosci 26:971–980CrossRef

11.

Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537–549CrossRef

12.

Chen F (2012) JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res 72:379–386CrossRef

13.

Dhanasekaran DN, Reddy EP (2008) JNK signaling in apoptosis. Oncogene 27:6245–6251CrossRef

14.

Bayne K (1996) Revised guide for the care and use of laboratory animals available. American Physiological Society. Physiologist 39(199):111–208

15.

Zheng Z, Chen H, Ke G, Fan Y, Zou H et al (2009) Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway. Diabetes 58:954–964CrossRef

16.

Yang H, Liu R, Cui Z, Chen ZQ, Yan S et al (2011) Functional characterization of 58-kilodalton inhibitor of protein kinase in protecting against diabetic retinopathy via the endoplasmic reticulum stress pathway. Mol Vis 17:78–84PubMedPubMedCentral

17.

Shi X, Liao S, Mi H, Guo C, Qi D et al (2012) Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Molecules 17:12868–12881CrossRef

18.

Chen W, Yao X, Zhou C, Zhang Z, Gui G et al (2017) Danhong huayu koufuye prevents diabetic retinopathy in streptozotocin-induced diabetic rats via antioxidation and anti-inflammation. Mediat Inflamm 2017:3059763

19.

Rao VR, Prescott E, Shelke NB, Trivedi R, Thomas P et al (2010) Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci 51:5198–5204CrossRef

20.

Liu N, Zhao N, Chen L, Cai N (2015) Survivin contributes to the progression of diabetic retinopathy through HIF-1α pathway. Int J Clin Exp Pathol 8:9161–9167PubMedPubMedCentral

21.

Mandarino LJ, Sundarraj N, Finlayson J, Hassell HR (1993) Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro. Exp Eye Res 57:609–621CrossRef

22.

Choi JA, Chung YR, Byun HR, Park H, Koh JY et al (2017) The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice. Toxicol Appl Pharmacol 315:80–89CrossRef

23.

Hammes HP (2005) Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 37(Suppl 1):39–43CrossRef

24.

Frank RN (2002) Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol 133:693–698CrossRef

25.

Wisniewska-Kruk J, Klaassen I, Vogels IM, Magno AL, Lai CM et al (2014) Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Exp Eye Res 122:123–131CrossRef

26.

Park SW, Yun JH, Kim JH, Kim KW, Cho CH et al (2014) Angiopoietin 2 induces pericyte apoptosis via α3β1 integrin signaling in diabetic retinopathy. Diabetes 63:3057–3068CrossRef

27.

Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M et al (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron 79:887–902CrossRef

28.

Xia N, Zhang Q, Wang ST, Gu L, Yang HM et al (2015) Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson’s disease model. Free Radic Biol Med 89:567–580CrossRef

29.

Schori H, Kipnis J, Yoles E, WoldeMussie E, Ruiz G et al (2001) Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci USA 98:3398–3403CrossRef

30.

Chen K, Zhang Q, Wang J, Liu F, Mi M et al (2009) Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res 1279:131–138CrossRef

31.

Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S et al (2008) Diabetes-enhanced tumor necrosis factor-α production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 172:1411–1418CrossRef

32.

Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M et al (2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15:1298–1306CrossRef

33.

Deng G, Moran EP, Cheng R, Matlock G, Zhou K et al (2017) Therapeutic effects of a novel agonist of peroxisome proliferator-activated receptor alpha for the treatment of diabetic retinopathy. Invest Ophthalmol Vis Sci 58:5030–5042CrossRef

34.

Park SH, Park JW, Park SJ, Kim KY, Chung JW et al (2003) Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46:1260–1268CrossRef

35.

Barcelona PF, Sitaras N, Galan A, Esquiva G, Jmaeff S et al (2016) p75NTR and its ligand ProNGF activate paracrine mechanisms etiological to the vascular, inflammatory, and neurodegenerative pathologies of diabetic retinopathy. J Neurosci 36:8826–8841CrossRef

36.

Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL et al (2012) Conditional Mullercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 32:15715–15727CrossRef

37.

Zhou CH, Zhang MX, Zhou SS, Li H, Gao J et al (2017) SIRT1 attenuates neuropathic pain by epigenetic regulation of mGluR1/5 expressions in type 2 diabetic rats. Pain 158:130–139CrossRef

38.

Zhang H, Li Q, Graham RK, Slow E, Hayden MR et al (2008) Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington’s disease. Neurobiol Dis 31:80–88CrossRef

39.

Zhao Y, Li Q, Li XY, Cui P, Gao F et al (2018) Involvement of mGluR I in EphB/ephrinB reverse signaling activation induced retinal ganglion cell apoptosis in a rat chronic hypertension model. Brain Res 1683:27–35CrossRef

40.

Lin BQ, Zhou JY, Ma Y, Deng YJ, Zheng CJ et al (2011) Preventive effect of danhong huayu koufuye on diabetic retinopathy in rats. Int J Ophthalmol 4:599–604PubMedPubMedCentral

41.

Dede AD, Tournis S, Dontas I, Trovas G (2014) Type 2 diabetes mellitus and fracture risk. Metabolism 63:1480–1490CrossRef

42.

Huang XP, Qiu YY, Wang B, Ding H, Tang YH et al (2014) Effects of Astragaloside IV combined with the active components of Panax notoginseng on oxidative stress injury and nuclear factor-erythroid 2-related factor 2/heme oxygenase-1 signaling pathway after cerebral ischemia-reperfusion in mice. Pharmacogn Mag 10:402–409CrossRef

43.

El Mesallamy HO, Metwally NS, Soliman MS, Ahmed KA, Abdel Moaty MM (2011) The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats. Cancer Cell Int 11:38CrossRef

44.

Tezel G, Chauhan BC, LeBlanc RP, Wax MB (2003) Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Invest Ophthalmol Vis Sci 44:3025–3033CrossRef

45.

Yang W, Tiffany-Castiglioni E, Koh HC, Son IH (2009) Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol Lett 191:203–210CrossRef

46.

Li X, Weng H, Xu C, Reece EA, Yang P (2012) Oxidative stress-induced JNK1/2 activation triggers proapoptotic signaling and apoptosis that leads to diabetic embryopathy. Diabetes 61:2084–2092CrossRef

47.

Zhao L, Jiao Q, Chen X, Yang P, Zhao B et al (2012) mGluR5 is involved in proliferation of rat neural progenitor cells exposed to hypoxia with activation of mitogen-activated protein kinase signaling pathway. J Neurosci Res 90:447–460CrossRef

48.

Fukuda K, Tesch GH, Nikolic-Paterson DJ (2008) c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury. Biochem Biophys Res Commun 366:710–716CrossRef

Titel: The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy
verfasst von: Yan-Ni Zhu
Guo-Jin Zuo
Qi Wang
Xiao-Ming Chen
Jin-Kui Cheng
Shu Zhang
Publikationsdatum: 03.01.2019
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 10/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-018-01061-w

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy

Abstract

Objective

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2019

The diagnostic value of optical coherence tomography angiography in diabetic retinopathy: a systematic review

One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma

Optical coherence tomography angiography findings in Behcet patients

Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy

Safety analysis and results of a borosilicate glass cartridge for no-touch graft loading and injection in Descemet membrane endothelial keratoplasty

Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde